LMP-specific activity of LMP-T products. Responders (Rs) received LMP-T products with slightly higher LMP2-specific and EBV activity (as demonstrated by using LCLs as stimulators in interferon-γ enzyme-linked immunospot assays, which may overlap with LMP1 and/or 2 responses) compared with nonresponders (NRs).